MIMICKING THE HUMORAL IMMUNE-RESPONSE IN-VITRO RESULTS IN ANTIGEN-SPECIFIC ISOTYPE SWITCHING SUPPORTED BY SPECIFIC AUTOLOGOUS T-HELPER CELLS - GENERATION OF HUMAN HIV-1-NEUTRALIZING IGG MONOCLONAL-ANTIBODIES FROM NAIVE DONORS

被引:25
作者
CHIN, LT
MALMBORG, AC
KRISTENSSON, K
HINKULA, J
WAHREN, B
BORREBAECK, CAK
机构
[1] LUND UNIV, DEPT IMMUNOTECHNOL, S-22007 LUND, SWEDEN
[2] SWEDISH INST INFECT DIS, DEPT VIROL, STOCKHOLM, SWEDEN
关键词
IN VITRO IMMUNIZATION; ISOTYPE SWITCH; HUMAN MONOCLONAL ANTIBODIES; HIV-1; V3; LOOP;
D O I
10.1002/eji.1830250305
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Molecular and cellular requirements for antigen-specific isotype switch of human B cells have been investigated by mimicking signaling occurring in germinal centers. Peripheral blood mononuclear cells from healthy seronegative blood donors were first primary immunized in vitro, using a synthetic immunogen containing both a T and B cell epitope, which generated specific IgM-secreting B cells. We used the apex of the V3 loop of gp120 as B cell epitope linked to a promiscuous T helper epitope from tetanus toxin. In parallel, CD4(+) T helper cell clones specific for the T epitope of the immunogen were established. In a secondary in vitro stimulation period, we co-cultured the antigen-specific T and B cells on CD32-transfected fibroblasts, together with an anti-CD40 monoclonal antibody. This resulted in isotype switching and human antigen-specific, IgG-secreting B cells were detected. This response was strictly dependent upon the presence of autologous T helper cells and the immunogen. Antigen-specific human B cells derived from this primary and secondary in vitro immunization were subsequently subjected to electrofield-induced somatic cell hybridization and hybridomas secreting human anti-V3 IgG monoclonal antibodies were isolated. One human antibody was further characterized and shown to be specific for the immunizing antigen with an affinity constant of 24 nM. This antibody also effectively neutralized different isolates of HTV-1, achieving a 50 % neutralization at 0.46 mu g/ml.
引用
收藏
页码:657 / 663
页数:7
相关论文
共 25 条
[1]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[2]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[3]   GROWING HUMAN LYMPHOCYTES-B IN THE CD40 SYSTEM [J].
BANCHEREAU, J ;
ROUSSET, F .
NATURE, 1991, 353 (6345) :678-679
[4]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[5]   KINETIC-ANALYSIS OF RECOMBINANT ANTIBODY-ANTIGEN INTERACTIONS - RELATION BETWEEN STRUCTURAL DOMAINS AND ANTIGEN-BINDING [J].
BORREBAECK, CAK ;
MALMBORG, AC ;
FUREBRING, C ;
MICHAELSSON, A ;
WARD, S ;
DANIELSSON, L ;
OHLIN, M .
BIO-TECHNOLOGY, 1992, 10 (06) :697-698
[6]   HUMAN MONOCLONAL-ANTIBODIES PRODUCED BY PRIMARY INVITRO IMMUNIZATION OF PERIPHERAL-BLOOD LYMPHOCYTES [J].
BORREBAECK, CAK ;
DANIELSSON, L ;
MOLLER, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3995-3999
[7]   HUMAN MABS PRODUCED BY PRIMARY INVITRO IMMUNIZATION [J].
BORREBAECK, CAK .
IMMUNOLOGY TODAY, 1988, 9 (11) :355-359
[8]  
BORREBAECK CAK, 1990, THERAPEUTIC MONOCLON
[9]  
BRENNER CA, 1989, BIOTECHNIQUES, V7, P1096
[10]   MOUSE X HUMAN HETEROHYBRIDOMAS AS FUSION PARTNERS WITH HUMAN B-CELL TUMORS [J].
CARROLL, WL ;
THIELEMANS, K ;
DILLEY, J ;
LEVY, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (01) :61-72